Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis

Summary

This study is aiming to investigate the efficacy of autologous mesenchymal stem cell (MSC) transplantation in 25 randomized patients with liver cirrhosis autologous mesenchymal stem cell will be derived from patients' bone marrows and will be infused via peripheral vein. Liver biopsies will be performed in every patient in the beginning and at 6th month.

Timeline

Start

2008-06

Primary completion

2012-07

Completion

2012-08

Drugs

Indications